跳至内容
Glassware & Plasticware
Category Image

OnSite™ HSV-2 IgG/IgM Rapid Test Kit, CE, 30 Tests

(0 评价)
SKU: R0213C
Brand: CTK Biotech
UoM:
Inquiry Required

Store Availability & Pickup
LabMart Limited - Tamale
NS-246, Via, 4388 Tamale-Kumbungu Rd, Tamale, Northern Region, 加纳
Not available
LabMart Limited
10 Rcecourse street, Accra, Greater Accra Region, 加纳
Not available
Add to quote
MOQ : 1.0
Estimated delivery Estimated delivery: 4-8 weeks
Telecel AirtelTigo Maestro Mastercard Visa MTN

The OnSite HSV-2 IgG/IgM Rapid Test CE is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of IgG and IgM antibodies to Herpes Simplex Virus type 2 (HSV-2) in human serum, plasma, or whole blood. By employing glycoprotein G2 (gG2), this test ensures type-specific detection, allowing clinicians to differentiate HSV-2 from HSV-1 and to determine whether the infection is acute (IgM) or chronic (IgG).

With rapid results in just 10 minutes and high agreement with market-leading European ELISA tests (95.3% IgG, 100% IgM), the OnSite HSV-2 IgG/IgM Rapid Test CE provides reliable diagnostic support at the point of care.

Key Features

  • Type-specific detection using HSV-2 glycoprotein G2.
  • Differentiates IgG and IgM antibodies, enabling identification of acute vs. chronic HSV-2 infection.
  • High confidence: agreement with European ELISA (95.3% IgG; 100% IgM).
  • Works with serum, plasma, or whole blood specimens.
  • Requires only a small sample volume (10 µL), reducing patient discomfort.
  • Rapid results in 10 minutes, supporting immediate treatment decisions.
  • 24-month shelf life (2–30°C), easy transport, and storage flexibility.

Kit Contents

Each kit (30 tests) contains:

  • One cassette device (per pouch).
  • One desiccant.
  • Capillary tubes (10 µL).
  • Sample diluent (REF SB-R0213, 5 mL/bottle).
  • Package insert (instructions for use).

Specifications

ParameterDetails
Product NameHSV-2 IgG/IgM Rapid Test CE
Catalog NumberR0213C
Format30 tests/kit
Specimen TypeSerum (S), Plasma (P), Whole Blood (WB)
DetectionIgG and IgM antibodies to HSV-2
PrincipleLateral Flow Chromatographic Immunoassay
Antigen UsedGlycoprotein G2 (type-specific)
Agreement with ELISA95.3% (IgG), 100% (IgM)
Sample Volume10 µL
Turnaround Time10 minutes
Storage2–30°C, 24 months
Regulatory StatusCE-marked

Applications

  • Rapid diagnosis of HSV-2 infections.
  • Differentiation of HSV-2 vs HSV-1 infections for precise treatment.
  • Acute vs. chronic infection identification via IgM/IgG detection.
  • Point-of-care testing in hospitals, diagnostic labs, and sexual health clinics.
  • Epidemiological surveillance and public health programs.


The OnSite HSV-2 IgG/IgM Rapid Test CE offers a fast, type-specific, and clinically reliable solution for detecting and differentiating HSV-2 antibodies. With its glycoprotein G2 specificity, rapid results, and excellent agreement with ELISA, this CE-marked test is a trusted diagnostic tool for healthcare providers. Its ease of use, small sample requirement, and high accuracy make it suitable for both clinical diagnosis and public health monitoring in diverse healthcare settings.

Application: Diagnostic Testing
Storage Temperature: Room Temperature
Product Type: Test Kit
Product Brand: CTK Biotech
Product Grade: Medical grade

The OnSite HSV-2 IgG/IgM Rapid Test CE is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of IgG and IgM antibodies to Herpes Simplex Virus type 2 (HSV-2) in human serum, plasma, or whole blood. By employing glycoprotein G2 (gG2), this test ensures type-specific detection, allowing clinicians to differentiate HSV-2 from HSV-1 and to determine whether the infection is acute (IgM) or chronic (IgG).

With rapid results in just 10 minutes and high agreement with market-leading European ELISA tests (95.3% IgG, 100% IgM), the OnSite HSV-2 IgG/IgM Rapid Test CE provides reliable diagnostic support at the point of care.

Key Features

  • Type-specific detection using HSV-2 glycoprotein G2.
  • Differentiates IgG and IgM antibodies, enabling identification of acute vs. chronic HSV-2 infection.
  • High confidence: agreement with European ELISA (95.3% IgG; 100% IgM).
  • Works with serum, plasma, or whole blood specimens.
  • Requires only a small sample volume (10 µL), reducing patient discomfort.
  • Rapid results in 10 minutes, supporting immediate treatment decisions.
  • 24-month shelf life (2–30°C), easy transport, and storage flexibility.

Kit Contents

Each kit (30 tests) contains:

  • One cassette device (per pouch).
  • One desiccant.
  • Capillary tubes (10 µL).
  • Sample diluent (REF SB-R0213, 5 mL/bottle).
  • Package insert (instructions for use).

Specifications

ParameterDetails
Product NameHSV-2 IgG/IgM Rapid Test CE
Catalog NumberR0213C
Format30 tests/kit
Specimen TypeSerum (S), Plasma (P), Whole Blood (WB)
DetectionIgG and IgM antibodies to HSV-2
PrincipleLateral Flow Chromatographic Immunoassay
Antigen UsedGlycoprotein G2 (type-specific)
Agreement with ELISA95.3% (IgG), 100% (IgM)
Sample Volume10 µL
Turnaround Time10 minutes
Storage2–30°C, 24 months
Regulatory StatusCE-marked

Applications

  • Rapid diagnosis of HSV-2 infections.
  • Differentiation of HSV-2 vs HSV-1 infections for precise treatment.
  • Acute vs. chronic infection identification via IgM/IgG detection.
  • Point-of-care testing in hospitals, diagnostic labs, and sexual health clinics.
  • Epidemiological surveillance and public health programs.


The OnSite HSV-2 IgG/IgM Rapid Test CE offers a fast, type-specific, and clinically reliable solution for detecting and differentiating HSV-2 antibodies. With its glycoprotein G2 specificity, rapid results, and excellent agreement with ELISA, this CE-marked test is a trusted diagnostic tool for healthcare providers. Its ease of use, small sample requirement, and high accuracy make it suitable for both clinical diagnosis and public health monitoring in diverse healthcare settings.

Package Insert
This will display Shipping & Return.

The OnSite HSV-2 IgG/IgM Rapid Test CE is a lateral flow chromatographic immunoassay for the qualitative detection and differentiation of IgG and IgM antibodies to Herpes Simplex Virus type 2 (HSV-2) in human serum, plasma, or whole blood. By employing glycoprotein G2 (gG2), this test ensures type-specific detection, allowing clinicians to differentiate HSV-2 from HSV-1 and to determine whether the infection is acute (IgM) or chronic (IgG).

With rapid results in just 10 minutes and high agreement with market-leading European ELISA tests (95.3% IgG, 100% IgM), the OnSite HSV-2 IgG/IgM Rapid Test CE provides reliable diagnostic support at the point of care.

Key Features

  • Type-specific detection using HSV-2 glycoprotein G2.
  • Differentiates IgG and IgM antibodies, enabling identification of acute vs. chronic HSV-2 infection.
  • High confidence: agreement with European ELISA (95.3% IgG; 100% IgM).
  • Works with serum, plasma, or whole blood specimens.
  • Requires only a small sample volume (10 µL), reducing patient discomfort.
  • Rapid results in 10 minutes, supporting immediate treatment decisions.
  • 24-month shelf life (2–30°C), easy transport, and storage flexibility.

Kit Contents

Each kit (30 tests) contains:

  • One cassette device (per pouch).
  • One desiccant.
  • Capillary tubes (10 µL).
  • Sample diluent (REF SB-R0213, 5 mL/bottle).
  • Package insert (instructions for use).

Specifications

ParameterDetails
Product NameHSV-2 IgG/IgM Rapid Test CE
Catalog NumberR0213C
Format30 tests/kit
Specimen TypeSerum (S), Plasma (P), Whole Blood (WB)
DetectionIgG and IgM antibodies to HSV-2
PrincipleLateral Flow Chromatographic Immunoassay
Antigen UsedGlycoprotein G2 (type-specific)
Agreement with ELISA95.3% (IgG), 100% (IgM)
Sample Volume10 µL
Turnaround Time10 minutes
Storage2–30°C, 24 months
Regulatory StatusCE-marked

Applications

  • Rapid diagnosis of HSV-2 infections.
  • Differentiation of HSV-2 vs HSV-1 infections for precise treatment.
  • Acute vs. chronic infection identification via IgM/IgG detection.
  • Point-of-care testing in hospitals, diagnostic labs, and sexual health clinics.
  • Epidemiological surveillance and public health programs.


The OnSite HSV-2 IgG/IgM Rapid Test CE offers a fast, type-specific, and clinically reliable solution for detecting and differentiating HSV-2 antibodies. With its glycoprotein G2 specificity, rapid results, and excellent agreement with ELISA, this CE-marked test is a trusted diagnostic tool for healthcare providers. Its ease of use, small sample requirement, and high accuracy make it suitable for both clinical diagnosis and public health monitoring in diverse healthcare settings.

Package Insert

This will display Shipping & Return.